N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

Sponsor: Centre Hospitalier le Mans • ClinicalTrials.gov ID: NCT05915663

Registry updated: 2026-09-10
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth. In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital. Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route. Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.

Interventions

  • nasogastric tube and orogastric tube (Other)
    nasogastric tube in period 1 and orogastric tube in period 2
  • orogastric tube and nasogastric tube (Other)
    orogastric tube in period 1 and nasogastric tube in period 2

Eligibility criteria

Inclusion Criteria: * patient in intensive care, intubated, ventilated * Adult * Requiring a gastric tube * With an expected duration of mechanical ventilation of more than 48 hours * Affiliated to social security * Patient or relative consent or, failing that, emergency inclusion of the patient Exclusion Criteria: * Pregnant, breast-feeding or parturient women * Patients under legal protection: curatorship and guardianship * Contraindication to placing a gastric tube through the nose or mouth * Patients who already have a gastric tube when they enter the service * Patient intubated for more than 24 hours * Patient intubated via the nasotracheal route

Conditions

Intubated Patient Requiring a Gastric Tube

Locations

  • CHU Angers — Angers, France
  • CH Cholet — Cholet, France
  • CHU Grenoble — Grenoble, France
  • CHD Vendée — La Roche-sur-Yon, France
  • Centre Hospitalier Du Mans — Le Mans, France
  • APHM - Hôpital Nord — Marseille, France
  • CHU Nantes — Nantes, France
  • CHRU Orléans — Orléans, France
  • APHP - Hôpital Saint-Antoine — Paris, France
  • CH Périgueux — Périgueux, France
  • CHU Poitiers — Poitiers, France
  • CHU Rennes — Rennes, France
  • CH Saint-Nazaire — Saint-Nazaire, France
  • CHRU Strasbourg - Hôpital de Hautepierre — Strasbourg, France
  • CHIC Toulon - La Seyne sur Mer — Toulon, France
  • CHRU Tours - Hôpital Bretonneau — Tours, France
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record